High Intensity Interval Training (HIT) in Patients With Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT01732705
- Lead Sponsor
- University of Copenhagen
- Brief Summary
The purpose of this study is to determine the effect of High Intensity Interval Training (HIT) on insulin sensitivity in skeletal muscle in patients with type 2 diabetes.
- Detailed Description
Physical exercise increases insulin sensitivity in skeletal muscle in healthy as well as in individuals with type 2 diabetes, but implies a considerable time commitment. High intensity interval training (HIT) is time-efficient exercise consisting of repeated bouts of short duration high intensive workloads. The aim of this study is to determine the effect of HIT in patients with type 2 diabetes, and to clarify the mechanisms of a possible positive effect of HIT.
Exercise is performed as 2 weeks one-legged training on an ergometer bicycle. Thus one leg serves as a control leg. Insulin sensitivity in trained and non-trained muscle will be measured after completion of the overall training program by euglycemic hyperinsulinemic clamp method and a-v catheterization of both legs. Muscle biopsies will be obtained during training period for measuring of muscle glycogen content, and muscle biopsies for further analysis obtained during the experimental day.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 20
- 10 subjects with Type 2 diabetes. 10 healthy control subjects.
- BMI 28-35
- diet or tablet treatment for diabetes
- regular physical activity
- diseases other than type 2 diabetes
- insulin treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Insulin sensitivity 2 days after last training session (day 17) Insulin sensitivity in trained and non-trained muscle will be measured by euglycemic hyperinsulinemic clamp method and a-v catheterization of both legs.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Xlab, Department of Biomedical Sciences, University of Copenhagen
🇩🇰Copenhagen, Denmark
Xlab, Department of Biomedical Sciences, University of Copenhagen🇩🇰Copenhagen, Denmark